Key points are not available for this paper at this time.
Design
Review
Answers are grounded in this paper and cite their sources.
No practice change from conference summary; leaves open prioritized directions for MH diagnostics and therapies.
Malignant hyperthermia (MH) is a complex pharmacogenetic disorder of muscle metabolism. To more closely examine the complexities of MH and other related muscle disorders, the Malignant Hyperthermia Association of the United States (MHAUS) recently sponsored a scientific conference at which an interdisciplinary group of experts gathered to share new information and ideas. In this Special Article, we highlight key concepts and theories presented at the conference along with exciting new trends and challenges in MH research and patient care.
No takes yet. Share an insight, caveat, or question.
Dirksen et al. (2011) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: